A detailed history of Aft, Forsyth & Sober, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aft, Forsyth & Sober, LLC holds 3,250 shares of LLY stock, worth $2.6 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
3,250
Previous 1,050 209.52%
Holding current value
$2.6 Million
Previous $867,000 192.16%
% of portfolio
0.87%
Previous 0.32%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$713.71 - $898.95 $1.57 Million - $1.98 Million
2,200 Added 209.52%
3,250 $2.53 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $763,560 - $978,663
1,050 New
1,050 $810,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Aft, Forsyth & Sober, LLC Portfolio

Follow Aft, Forsyth & Sober, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Sober, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Sober, LLC with notifications on news.